Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ―
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― have?
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― has 80 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― published?
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― has 2021 year in the ScholarIQ index.
What is the open-access status of Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ―?
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― has diamond oa status in the ScholarIQ index.
What is the DOI of Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ―?
The DOI for Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― is on the source record.
What is the PMID of Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ―?
The PMID for Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― is on the source record.
What is the OpenAlex record for Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ―?
The OpenAlex for Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Results From the PARALLEL-HF Study ― is on the source record.